Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics
Crossref DOI link: https://doi.org/10.1038/nbt.3882
Published Online: 2017-06-07
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hafner, Marc http://orcid.org/0000-0003-1337-7598
Niepel, Mario http://orcid.org/0000-0003-1415-6295
Sorger, Peter K
Text and Data Mining valid from 2017-06-01
Article History
First Online: 7 June 2017
Competing interests
: The authors declare no competing financial interests.